Jivko Stoyanov is leading the group of SCI Population Biobanking and Translational Medicine at the Swiss Paraplegic Research in Nottwil, Switzerland and is Titularprofessor at the Intitute of Social and Preventive Medicine at the University of Bern. At ISPM he works closely with PD Dr Marija Glisic and Prof. Oscar Franco on projects involving epidemiology of Spinal Cord Injury. He received a PhD in molecular biology from the University of Birmingham, UK, M.Sc. in Translational Medicine from the University of Edinburgh,Scotland,  M.Sc. in Biotechnology from the University of Sofia, Bulgaria and an EMBA from the University of St Gallen, Switzerland. From 2001 till 2007  he was employed at the University of Bern by the former Institute of Clinical Pharmacology and the former Insitute of Surgical Technology and Biomechanics. At the Swiss Paraplegic Research, since 2007 he established a laboratory which works on topics related to the spinal cord injury (SCI) and heads the biobank of the multicenter Swiss Spinal Cord Injury Cohort Study (SwiSCI). Prof Stoyanov has been teaching since the beginning of the Master of Biomedical Engineering Program. He also supervises MSc as well as PhD students registered at the Universities of Bern and Lucerne at the state of the art laboratories in Nottwil.


Affiliated professor (Titularprofessor) at the Institute of Social and Preventive Medicine, University of Bern.

Head and establisher of SwiSCI Biobank – Swiss national biorepository for samples of persons with SCI.

Group leader at the Spine Injury Research Unit of Swiss Paraplegic Research, Nottwil. Supervising staff scientists and students at PhD, MD, MSc and BSc level.

Staff scientist at the Swiss Paraplegic Research. Established a new laboratory focused at the use of mesenchymal stem cells for intervertebral disc repair.

Postdoctoral fellow at the Institute of Surgical Technology and Biomechanics. Work on basic and applied projects related to intervertebral disc biology.

Postdoctoral fellow at the Institute of Clinical Pharmacology, University of Bern Molecular biology of copper homeostasis. Co-supervisor of M.Sc. and Ph.D. students on projects in Molecular Microbiology.


Executive MBA, HSG (University of St Galen), Switzerland

Clinical Epidemiology: from Theory to Applications (2 ECTS); SSPH, Prof. A. Hofman, Harvard,

Good Clinical Practice Sponsor-Investigator Certificate, Swiss Paraplegic Centre, Nottwil, Switzerland.

Operative Excellence Certificate (EFQM Model), Swiss Excellence Forum.

Good Clinical Practice Investigator Certificate, CTU Swiss Paraplegic Centre, Nottwil, Switzerland.

Course in Randomised Controlled Trials (20 CTS), University of Oxford, UK, Prof. Mike Clarke

Habilitation as a Privatdozent in Biochemistry and Molecular Biology at the University of Bern.

M.Sc in Translational Medicine, College of Medicine at University of Edinburgh, UK

Ph.D. in Molecular microbiology, School of Biosciences, University of Birmingham, UK:

Postgraduate specialization in ecotoxicology (6 months), Technical University of Denmark, Copenhagen

M.Sc. in Industrial Biotechnology, University of Sofia, Bulgaria.